India, July 31 -- The Government of India has issued a release:
Department of Pharmaceuticals, vide S.O. 3516(E) dated 30.06.2026 has notified amendments to some of the existing provisions of the Drugs (Prices Control) Order, 2013 which inter alia addresses the issues regarding liability of drugs manufacturer in overcharging cases, need for prior approval of retail price for a new drug that an existing manufacturer intends to launch etc. The amendments made vide the aforesaid notification will promote ease of doing business and incentivizes innovations in the sector. The said notification is available at the web link: https://pharma-dept.gov.in/sites/default/files/13th%20Amendment%20%20S.O.%203516%20%28E%29%20dated%2030%20June%202026.pdf....